Introduction
The utility of implantable cardioverter-defibrillators (ICDs) to protect against sudden cardiac death has been well established.^"^ As the number of patients with ICDs has increased, so has the number of patients with devices that have developed battery depletion and require a generator replacement. The frequency with which defibrillation and sensing system failures are identified during generator replacement procedures has not previously been reported. Therefore, the purpose of this study was to determine the value of complete lead system assessment at the time of ICD replacement.
Methods

Patient Characteristics
The patient population consisted of 55 consecutive patients undergoing an ICD generator replacement between October 1993 and November 1994. One of the patients herein presented had elevated defibrillation energy requirements (DER) and has been reported elsewhere.^ The mean age of the patients was 63 ± 10 years, 40 males and 15 females. Forty-three patients had coronary artery disease, 7 had idiopathic dilated cardiomyopathy, 3 had other forms of cardiomyopathy, and 2 had structurally normal hearts. The mean left ventricular ejection fraction was 0.29 ± 0.10. Thirty-five of the 55 patients presented with a cardiac arrest, 16 presented with ventricular tachycardia, and 4 presented with syncope. Forty-nine patients had an epicardial lead system, and 6 patients had a nonthoracotomy lead system [CPI Endotak System, model 
Routine ICD FoUovir-Up
All patients underwent routine outpatient ICD evaluation of the sensing lead every 3 months by one of the investigators. Sensing function was assessed with a beep-o-gram for CPI devices, or with real-time telemetry and R wave (mV) assessment for Intermedics and Medtronic devices.
ICD Generator Replacement
ICD generator replacement was performed when tbe battery status indicated, as recommended by the manufacturer. At the time of ICD generator replacement, the patients were brought to tbe electropbysiology laboratory in a postabsorptive and unsedated state. Each patient signed an informed consent prior to all procedures. The site of tbe generator was inspected under fluoroscopy, to localize the header and its relative position to the lead(s). Sedation for the procedure was achieved with a combination of intravenous benzodiazepines and opiates. After infiltration witb local anesthetic, an incision was made at tbe site of the previous scar. Using blunt dissection, the old generator was extracted and then disconnected from the leads. After demonstration of adequate defibrillation and sensing function, a new device was implanted, the pocket was irrigated with a gentamicin solution, and the incision was closed.
Replacement generators from CPI, Intermedics, Inc., Medtronic, Inc., and Ventritex (Sunnyville, CA, USA) were used. A CPI device (model 1555, 1600, 1625, 1700, 1705, or 1715) was implanted in 45 patients, an Intermedics RES-Q (model 101-01) was implanted in 5 patients, a Medtronic PCD (model 7217B) was implanted in 2 patients, and a Ventritex VllOC was implanted in 3 patients.
Assessment of Sensing Lead Function
After extraction of tbe ICD and disconnection of the leads from tbe ICD, the sensing leads were visually examined for a breach of insulator integrity. Tbe pacing threshold and lead impedance were measured. If the insulation of the sensing lead was observed to bave failed, or if tbe pacing threshold was > 5 V, or the lead impedance was > 1000 Cl, the lead was considered to be defective.
Defibrillation Energy Requirement Determination
An adequate DER was defined as at least 10 J less than the maximum output of the ICD. Ventricular fibrillation was induced using alternating current, and 10 seconds later a 20 J shock was delivered. If ventricular fibrillation was converted to sinus rbytbm, an additional successful defibrillation at tbe same or less energy was required to demonstrate an adequate DER. Defibrillation was also tested with the device to ensure proper function. If tbe initial 20-J shock was unsuccessful, then 25 J was used during tbe subsequent induction of ventricular fibrillation.
Statistical Analysis
Continuous variables are expressed as tbe mean ± 1 SD.
Results
Major Findings
The ICD system was noted to be intact in 51 of the 55 patients. The mean DER at tbe time of ICD replacement was 16 ± 7 J (5-25 J). Lead system failures were identified in 4 of the 55 patients, 40 ± 6 months after lead system implantation (33-49 months). Sensing lead failure was identified in three patients during tbe device replacement procedure, and failure to defibrillate was identified in IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR REPLACEMENT one patient during assessment of the DER at the time of ICD generator replacement, 40 ± 7 months (33-49 months), and 41 months, respectively, after lead system implantation.
Sensing or Defibritlation System Faiture
In three patients with an epicardial lead system, a sensing lead failure (model 501170, Daig Corp., Minnetonka, MN, USA) was detected when the defibrillator pocket was opened in the electrophysiology laboratory and the sensing lead evaluated. In addition to the identification of oversensing in all of these patients, a high impedance (> 1000) was demonstrated in 2 patients, a pacing threshold of > 5 V was observed in 3 patients, and a visually apparent loss of insulator integrity was noted in 1 patient. All three patients subsequently underwent an uncomplicated sensing lead replacement with an endocardial lead via the subclavian vein.
In one patient, an elevated DER was noted during the replacement procedure with a monophasic shock that was identical to the original waveform. An adequate DER was achieved when the original ICD was replaced without complication using a biphasic device (CPI model 1625).
Discussion
This study demonstrates that approximately 10% of patients undergoing ICD generator replacement due to battery depletion may be found to have a previously undetected sensing or defibrillation system failure. The usefulness of the beep-o-gram to detect a sensing problem has been previously reported.^'^ In this series, a clinically undetected sensing lead abnormality was identified in three patients by direct evaluation of the lead at the time of device replacement, despite routine device surveillance.
Lead fractures of epicardial and nonthoracotomy lead systems have been reported.^"^^ However, in these previous reports, the fractures were usually discovered because of inappropriate shocks or during the course of routine followup.^~^'' The data from the present study are the first data to suggest the importance of lead system assessment during generator replacement.
In one patient in the present report, the DER was noted to be unacceptably elevated 41 months after implantation with an epicardial defibrillator system. While energy requirements with an epicardial lead system are not thought to change chronically,^^ an elevation in the DER may occur at least during the first 6 months after a nonthoracotomy lead system is implanted. ^^ The results of this study may not be generalizable to replacement of ICDs in patients with nonthoracotomy lead systems, although failure of nonthoracotomy lead systems can also develop over time.^^~^^ Together, the results of prior and present studies suggest that DER testing should be performed during generator replacement.
Clinical Implications
Sensing lead function and defibrillation efficacy should be carefully evaluated prior to and during the replacement procedure. Evaluation of lead system integrity may not be complete with a noninvasive evaluation, and therefore, both defibrillation and sensing functions should be appropriately evaluated at the time of ICD generator replacement.
